Back to Search Start Over

Chimerism does not predict for outcome after alemtuzumab based conditioning.

Authors :
Michaelis, L.
Lin, S.
Joseph, L.
Artz, A. S.
Kline, J.
Pollyea, D.
Stock, W.
Rich, E.
Collins-Jones, D.
Casey, B.
Cerro, P. Del
van Besien, K.
Source :
Bone Marrow Transplantation. Jul2007, Vol. 40 Issue 2, p181-181. 1p.
Publication Year :
2007

Abstract

A letter to the editor is presented in response to the article about the combination of fludarabine, melphalan and alemtuzumab, which was published online on May 14, 2007.

Subjects

Subjects :
*LETTERS to the editor
*ANTINEOPLASTIC agents

Details

Language :
English
ISSN :
02683369
Volume :
40
Issue :
2
Database :
Academic Search Index
Journal :
Bone Marrow Transplantation
Publication Type :
Academic Journal
Accession number :
25621367
Full Text :
https://doi.org/10.1038/sj.bmt.1705707
Full Text Access
View/download PDF

Tools

Authors Abstract Subjects Details